yttrium Y 90 DOTA monoclonal antibody HuAFP31

yttrium Y 90 DOTA monoclonal antibody HuAFP31 information and resources from the National Cancer Institute

yttrium Y 90 DOTA monoclonal antibody HuAFP31

A radioimmunoconjugate comprised of the monoclonal antibody HuAFP31, directed against alpha fetoprotein, that is conjugated to the chelating agent tetra-azacyclododecanetetra-acetic acid (DOTA) and radiolabeled with the beta-emitting radioisotope Yttrium Y90. Yttrium Y 90 DOTA monoclonal antibody HuAFP31 binds to tumor cells expressing alpha fetoprotein, selectively delivering a cytotoxic dose of beta radiation.

yttrium Y 90 DOTA monoclonal antibody HuAFP31 -->

Home | About | Search topics | Cancers | Treatment | Medications
Onconews provides free news and resources on cancer-related topics.

Copyright onconews.org 2005-2006.
All Rights Reserved.
Google
 
Web onconews.org